Latest News and Press Releases

Dublin, May 07, 2025 (GLOBE NEWSWIRE) -- The "Plant Biotechnology Market by Product Type (Crop Protection & Nutrition Solution Products, Biotech Seed & Traits, Synthetic Biology Enabled...

Fort Collins, Colorado, April 06, 2024 (GLOBE NEWSWIRE) -- The Plant Biotechnology Market was valued at USD 105.1 Billion in 2023 and is anticipated to grow CAGR at 11.4% and reach USD 276.9 Billion...

Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Plant Biotechnology Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The "Global Strategic...

Initiated International Launch Process For VLN®, First Sales Planned by First Quarter 2022First Revenue From Hemp/Cannabis Franchise to Commence in Second Half of 2021Third Plant-Based Franchise to be...

Close Partnership With Aurora Cannabis Inc. to Enforce Shared Global Biosynthesis IP Rights Against Infringement and Actively Explore Commercial Development Opportunities; Monetization of Key Patented...

BUFFALO, N.Y., June 07, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine...

WILLIAMSVILLE, N.Y., March 12, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low...

Key Business and Financial Highlights 22nd Century has a tremendous global commercial opportunity in the more than $800 billion markets across the tobacco and hemp/cannabis industry.Securing Modified...

WILLIAMSVILLE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low...